← Leaderboards
Susanta K Hui
Beckman Research Institute/City Of Hope
$5,584,345
Attributed
$8,359,654
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,359,654 · 4
By mechanism
R01$8,138,394 · 3
R03$221,260 · 1
Top collaborators
- Jeffrey Y Wong5 shared
- Marcin Kortylewski3 shared
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Jeffrey Y Wong$4,970,582
- Guido Marcucci$19,718,636
- Bin Zhang$2,891,856
- Marcin Kortylewski$7,220,327
- Anthony Stein$260,950
Others in their field
Top investigators on “Bone Marrow”
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- David Heimbrook · Leidos Biomedical Research, Inc.$56,049,457
- Richard L Schilsky · University Of Chicago$50,043,295
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,148,202
- J. Mark Cline · Wake Forest University$31,844,583
Research focus
Bone MarrowToxic EffectRadiationOrganRegimenMarrowCellsRelapseMonitorResearch PersonnelCause Of DeathEngraftmentRecurrenceIrradiationDoseLeukemiaRefractoryWhole-Body IrradiationRecurrent DiseaseImmunocompetentBloodClinical TrialsConditioningAllogenic
Grant awards (20)
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia$715,641
R01 · FY2025 · CA
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation$343,450
R01 · FY2025 · HL · contact PI
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia$687,979
R01 · FY2024 · CA
Conformal Total Body and Marrow Irradiation for Leukemia$657,603
R01 · FY2024 · CA · contact PI
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation$343,450
R01 · FY2024 · HL · contact PI
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia$711,258
R01 · FY2023 · CA
Conformal Total Body and Marrow Irradiation for Leukemia$677,328
R01 · FY2023 · CA · contact PI
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation$362,450
R01 · FY2023 · HL · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$687,213
R01 · FY2022 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$705,084
R01 · FY2021 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$708,512
R01 · FY2020 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$209,962
R01 · FY2015 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$103,363
R01 · FY2015 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$303,925
R01 · FY2014 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$294,526
R01 · FY2013 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$313,325
R01 · FY2012 · CA · contact PI
Conformal Total Body and Marrow Irradiation for Leukemia$313,325
R01 · FY2011 · CA · contact PI
A Novel Long-Lived 41Ca Marker To Assess Bone Turnover For Breast Cancer Patients$73,255
R03 · FY2009 · AR · contact PI
A Novel Long-Lived 41Ca Marker To Assess Bone Turnover For Breast Cancer Patients$73,255
R03 · FY2008 · AR · contact PI
A Novel Long-Lived 41Ca Marker To Assess Bone Turnover For Breast Cancer Patients$74,750
R03 · FY2007 · AR · contact PI